Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus

Jing Zhou1, Shi-Qi Wang2, Jian-Chao Wei3

  • 1Key Laboratory of Animal Diseases Diagnosis and Immunology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China. 2015107081@njau.edu.cn.

Viruses
|January 12, 2017
PubMed

Insights

Interferon-alpha (IFNα) inhibits Japanese encephalitis virus (JEV) replication through pathways independent of Mx1 and Mx2 proteins. This study found that Mx proteins do not mediate the antiviral activity of IFNα against JEV.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Mx proteins are interferon-induced GTPases found in vertebrates, known to inhibit viral replication.
  • The specific role of Mx proteins in interferon-mediated suppression of Japanese encephalitis virus (JEV) remains unelucidated.

Purpose of the Study:

  • To investigate the role of Mx1 and Mx2 proteins in interferon-alpha (IFNα)-induced restriction of JEV replication.
  • To determine if IFNα's antiviral activity against JEV is dependent on Mx1 or Mx2 expression.

Main Methods:

  • Knockdown of Mx1 or Mx2 using siRNA in IFNα-treated PK-15 and BHK-21 cells, followed by JEV challenge.
  • Assessment of progeny virus production via plaque assay, RT-qPCR, and Western blotting.
  • Evaluation of exogenous Mx1 or Mx2 expression and the effect of Brefeldin A (BFA) on JEV proliferation.

Main Results:

  • Depletion of Mx1 or Mx2 did not alter IFNα-mediated restriction of JEV replication.
  • Exogenous expression of Mx1 or Mx2 did not affect IFNα's inhibitory activity against JEV.
  • Brefeldin A inhibited JEV replication but not maturation, suggesting potential as an antiviral.

Conclusions:

  • IFNα inhibits JEV infection through Mx-independent pathways.
  • Mx1 and Mx2 proteins are not essential mediators of IFNα's antiviral effect against JEV.
  • Brefeldin A shows promise as a novel antiviral reagent for JEV infection.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
18.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
703
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.3K